World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT01994330
Date of registration: 14/11/2013
Prospective Registration: No
Primary sponsor: Pontificia Universidad Catolica de Chile
Public title: Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
Scientific title: Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
Date of first enrolment: June 2009
Target sample size: 13
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01994330
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  Phase 4
Countries of recruitment
Chile
Contacts
Name:     guillermo lema, profesor titular
Address: 
Telephone:
Email:
Affiliation:  Pontificia Universidad Catolica de Chile
Name:     esperanza carrasco, anesthesiologist
Address: 
Telephone:
Email:
Affiliation:  Pontificia Universidad Catolica de Chile
Name:     rodrigo lopez, anesthesiologist
Address: 
Telephone:
Email:
Affiliation:  Pontificia Universidad Catolica de Chile
Key inclusion & exclusion criteria

Inclusion Criteria:

- severe aortic stenosis defined as mean transvalvular gradient greater or equal to 40
mmHg ot transvalvular area less than 1 cm2

- scheduled for aortic valve replacement surgery

Exclusion Criteria:

- combined surgery (plus coronary artery bypass graft or other valve replacement/plasty)

- Infective Endocarditis

- previously known haemostatic disorder

- previous treatment with oral anticoagulants or IIb-IIIa inhibitors (we did not exclude
those on acetyl-salicylic acid)



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Heye´s Syndrome
Severe Aortic Stenosis
Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis
Intervention(s)
Drug: desmopressin
Primary Outcome(s)
blood loss [Time Frame: once patient arrives to post anesthesia care unit (approximately 6 hours after drug administration]
Secondary Outcome(s)
need of transfusion [Time Frame: 48 hours post administration]
postoperative hematocrit [Time Frame: the morning after surgery (18-24 hours after drug administration)]
Secondary ID(s)
RVA
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ferring Pharmaceuticals
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history